ID   HuO9-H3
AC   CVCL_WL11
SY   Hu09-H3; H3
DR   Wikidata; Q94309126
RX   PubMed=14669798;
RX   PubMed=26320182;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic.
CC   Doubling time: 49.3 hours (PubMed=14669798).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1298 ! HuO9
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=14669798; DOI=10.1023/A:1027355610603;
RA   Nakano T., Tani M., Ishibashi Y., Kimura K., Park Y.-B., Imaizumi N.,
RA   Tsuda H., Aoyagi K., Sasaki H., Ohwada S., Yokota J.;
RT   "Biological properties and gene expression associated with metastatic
RT   potential of human osteosarcoma.";
RL   Clin. Exp. Metastasis 20:665-674(2003).
//
RX   PubMed=26320182; DOI=10.18632/oncotarget.5177;
RA   Ren L., Mendoza A., Zhu J., Briggs J.W., Halsey C., Hong E.S.,
RA   Burkett S.S., Morrow J.J., Lizardo M.M., Osborne T., Li S.Q.,
RA   Luu H.H., Meltzer P.S., Khanna C.;
RT   "Characterization of the metastatic phenotype of a panel of
RT   established osteosarcoma cells.";
RL   Oncotarget 6:29469-29481(2015).
//